425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. have announced a proposed business combination, with Strive planning to issue Class A common stock for the transaction.

Summary

• Strive, Inc. filed a Form 425 regarding its proposed business combination with Semler Scientific, Inc.
• The communication was reposted on X.com by Arshia Sarkhani, Chief Marketing Officer of Strive, Inc., on September 22, 2025.
• The filing includes a cautionary statement about forward-looking statements, highlighting inherent risks and uncertainties associated with the proposed transaction.
• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the merger.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus, which will be sent to Semler Scientific stockholders for approval of the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a procedural announcement of a proposed merger, accompanied by extensive standard risk disclosures. It does not contain specific financial results or operational updates that would significantly sway sentiment positively or negatively, focusing instead on the process and potential future outcomes.

Positives

• The proposed transaction is anticipated to yield strategic and financial benefits for the combined company, including potential cost savings and strategic gains.

Negatives

• The proposed transaction will result in dilution for existing Strive shareholders due to the issuance of additional shares of Class A common stock.
• There is a risk that the integration of the two companies may be more difficult, time-consuming, or costly than initially expected.
• The transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.

Risks

• The merger agreement could be terminated by either Strive or Semler Scientific.
• Conditions to closing the transaction may not be received or satisfied on a timely basis or at all, potentially preventing the merger from closing.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company, impacting the transaction or future operations.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected, partly due to risks associated with Bitcoin and other digital assets, general economic conditions, and regulatory changes.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships could occur.
• Changes in Strive's or Semler Scientific's share price before closing could negatively impact the transaction.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed business combination, including cost savings and strategic gains. However, they caution that actual results may differ materially from these forward-looking statements due to various risks, including integration challenges, market conditions, and regulatory changes. The timing of the closing and the successful integration of the combined businesses are key expectations.

Industry Context

NA

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of new Class A common stock.
• Semler Scientific stockholders will vote on the proposed transaction.
• Customers and employees of both companies may experience changes or adverse reactions as a result of the announcement or completion of the merger.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus, which will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive, Semler Scientific, Merger, Business Combination, SEC Filing, Form 425, Acquisition, Corporate Governance, Bitcoin Treasury